Literature DB >> 20817213

Nonalcoholic steatohepatitis and increased risk of chronic kidney disease.

Kohichiroh Yasui1, Yoshio Sumida, Yasukiyo Mori, Hironori Mitsuyoshi, Masahito Minami, Yoshito Itoh, Kazuyuki Kanemasa, Hiroaki Matsubara, Takeshi Okanoue, Toshikazu Yoshikawa.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) and chronic kidney disease (CKD) share common features. Both are associated with visceral obesity, type 2 diabetes mellitus, metabolic syndrome, and insulin resistance. However, the relationship between NAFLD and CKD is poorly understood. We examined the prevalence of and risk factors for CKD in patients with NAFLD. We analyzed 174 Japanese patients with liver biopsy-proven NAFLD using a cross-sectional design. Chronic kidney disease was defined as estimated glomerular filtration rate less than 60 mL/min per 1.73 m(2) and/or overt proteinuria. Of 174 NAFLD patients, 92 (53%) exhibited histologic characteristics of nonalcoholic steatohepatitis (NASH), the progressive form of NAFLD; and 82 (47%) had non-NASH NAFLD. Chronic kidney disease was present in 24 (14%) of 174 NAFLD patients. The prevalence of CKD was significantly higher in NASH patients (19 of 92; 21%) than non-NASH patients (5 of 82; 6%). The presence of CKD was associated with a higher body mass index and the presence of hypertension and NASH. Our results demonstrated a high prevalence of CKD among patients with NASH.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20817213     DOI: 10.1016/j.metabol.2010.07.022

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  48 in total

Review 1.  Increased risk of cardiovascular disease and chronic kidney disease in NAFLD.

Authors:  Enzo Bonora; Giovanni Targher
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-05-08       Impact factor: 46.802

2.  Liver stiffness assessed by transient elastography as a potential indicator of chronic kidney disease in patients with nonalcoholic fatty liver disease.

Authors:  Shaoyou Qin; Song Wang; Xu Wang; Jiangbin Wang
Journal:  J Clin Lab Anal       Date:  2018-09-21       Impact factor: 2.352

Review 3.  Preventive Strategies for Nonalcoholic Fatty Liver Disease After Liver Transplantation.

Authors:  Narendra S Choudhary; Sanjiv Saigal
Journal:  J Clin Exp Hepatol       Date:  2019-05-30

4.  Awareness of Nonalcoholic Fatty Liver Disease Is Increasing but Remains Very Low in a Representative US Cohort.

Authors:  Amandeep Singh; Amaninder S Dhaliwal; Shailainder Singh; Atul Kumar; Rocio Lopez; Mohit Gupta; Mazen Noureddin; William Carey; Arthur McCullough; Naim Alkhouri
Journal:  Dig Dis Sci       Date:  2019-06-11       Impact factor: 3.199

Review 5.  Therapeutic implications of shared mechanisms in non-alcoholic fatty liver disease and chronic kidney disease.

Authors:  Mehmet Kanbay; Mustafa C Bulbul; Sidar Copur; Baris Afsar; Alan A Sag; Dimitrie Siriopol; Masanari Kuwabara; Silvia Badarau; Adrian Covic; Alberto Ortiz
Journal:  J Nephrol       Date:  2020-05-21       Impact factor: 3.902

6.  Nonalcoholic fatty liver disease alters microcystin-LR toxicokinetics and acute toxicity.

Authors:  John D Clarke; Anika Dzierlenga; Tarana Arman; Erica Toth; Hui Li; Katherine D Lynch; Dan-Dan Tian; Michael Goedken; Mary F Paine; Nathan Cherrington
Journal:  Toxicon       Date:  2019-03-05       Impact factor: 3.033

7.  Relations of liver fat with prevalent and incident chronic kidney disease in the Framingham Heart Study: A secondary analysis.

Authors:  Robert M Wilechansky; Alison Pedley; Joseph M Massaro; Udo Hoffmann; Emelia J Benjamin; Michelle T Long
Journal:  Liver Int       Date:  2019-05-24       Impact factor: 5.828

Review 8.  Implications of Nonalcoholic Steatohepatitis as the Cause of End-Stage Liver Disease Before and After Liver Transplant.

Authors:  Anchalia Chandrakumaran; Mohammad Shadab Siddiqui
Journal:  Gastroenterol Clin North Am       Date:  2020-03       Impact factor: 3.806

9.  Association between non-alcoholic fatty liver disease and chronic kidney disease in population with prediabetes or diabetes.

Authors:  Yongqiang Li; Shuangshuang Zhu; Bin Li; Xiaofei Shao; Xinyu Liu; Aiqun Liu; Bifang Wu; Ying Zhang; Honglei Wang; Xiaohong Wang; Kangping Deng; Qin Liu; Min Huang; Hongmei Liu; Harry Holthöfer; Hequn Zou
Journal:  Int Urol Nephrol       Date:  2014-08-07       Impact factor: 2.370

10.  Non-alcoholic fatty liver disease increases the risk of incident chronic kidney disease.

Authors:  Leonard Kaps; Christian Labenz; Peter R Galle; Julia Weinmann-Menke; Karel Kostev; Jörn M Schattenberg
Journal:  United European Gastroenterol J       Date:  2020-07-23       Impact factor: 4.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.